By now you probably know the record of the life-saving EpiPen and the company that took it from a product that generated a measly $200 million in 2007 and turned it into a $1 billion-a-year cash-printing machine. That company,Mylan, used a natty little trick: It simply raised the price . And it may enjoy taken Congress and the media awhile to catch on, and but consumers definitely knew. In fact,allergy sufferers were filing complaints with the FTC about Mylan’s price gouging as early as 2012.
Read more...
Source: gawker.com